JP2013511566A5 - - Google Patents

Download PDF

Info

Publication number
JP2013511566A5
JP2013511566A5 JP2012540414A JP2012540414A JP2013511566A5 JP 2013511566 A5 JP2013511566 A5 JP 2013511566A5 JP 2012540414 A JP2012540414 A JP 2012540414A JP 2012540414 A JP2012540414 A JP 2012540414A JP 2013511566 A5 JP2013511566 A5 JP 2013511566A5
Authority
JP
Japan
Prior art keywords
protein
factor
pegylated protein
buffer
purified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012540414A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013511566A (ja
JP5827955B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2010/068112 external-priority patent/WO2011064247A1/en
Publication of JP2013511566A publication Critical patent/JP2013511566A/ja
Publication of JP2013511566A5 publication Critical patent/JP2013511566A5/ja
Application granted granted Critical
Publication of JP5827955B2 publication Critical patent/JP5827955B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012540414A 2009-11-24 2010-11-24 Peg化タンパク質の精製方法 Active JP5827955B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP09176881 2009-11-24
EP09176881.2 2009-11-24
US26448609P 2009-11-25 2009-11-25
US61/264,486 2009-11-25
PCT/EP2010/068112 WO2011064247A1 (en) 2009-11-24 2010-11-24 Method of purifying pegylated proteins

Publications (3)

Publication Number Publication Date
JP2013511566A JP2013511566A (ja) 2013-04-04
JP2013511566A5 true JP2013511566A5 (enExample) 2014-01-16
JP5827955B2 JP5827955B2 (ja) 2015-12-02

Family

ID=41401820

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012540414A Active JP5827955B2 (ja) 2009-11-24 2010-11-24 Peg化タンパク質の精製方法

Country Status (5)

Country Link
US (1) US8697844B2 (enExample)
EP (1) EP2504349B1 (enExample)
JP (1) JP5827955B2 (enExample)
CN (2) CN107383158A (enExample)
WO (1) WO2011064247A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5876208B2 (ja) 2006-12-15 2016-03-02 バクスター・インターナショナル・インコーポレイテッドBaxter International Incorp0Rated 延長されたinvivo半減期を有する第VIIa因子−(ポリ)シアル酸結合体
US8809501B2 (en) 2009-07-27 2014-08-19 Baxter International Inc. Nucleophilic catalysts for oxime linkage
JP5909755B2 (ja) 2009-07-27 2016-04-27 リポクセン テクノロジーズ リミテッド 非血液凝固タンパク質の糖ポリシアル酸化
US8642737B2 (en) 2010-07-26 2014-02-04 Baxter International Inc. Nucleophilic catalysts for oxime linkage
EP3093029A1 (en) 2009-07-27 2016-11-16 Baxalta GmbH Blood coagulation protein conjugates
SG178141A1 (en) 2009-07-27 2012-03-29 Baxter Int Blood coagulation protein conjugates
DK2654794T3 (da) 2010-12-22 2020-06-08 Baxalta GmbH Materialer og fremgangsmåder til konjugering af et vandopløseligt fedtsyrederivat til et protein
KR102020995B1 (ko) * 2017-10-30 2019-09-16 한국코러스 주식회사 콜로니자극인자와 폴리올이 접합된 접합물을 고수율로 제조하는 방법
US12208142B2 (en) * 2017-12-29 2025-01-28 Hoffmann-La Roche Inc. Process for providing PEGylated protein composition
JP7227633B2 (ja) * 2017-12-29 2023-02-22 エフ. ホフマン-ラ ロシュ エージー. Peg化タンパク質組成物を提供するための方法
HRP20220041T1 (hr) 2017-12-29 2022-04-15 F. Hoffmann - La Roche Ag Postupak za dobivanje pegiliranog proteinskog pripravka

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714583A (en) 1995-06-07 1998-02-03 Genetics Institute, Inc. Factor IX purification methods
AU6255096A (en) 1995-06-07 1996-12-30 Mount Sinai School Of Medicine Of The City University Of New York, The Pegylated modified proteins
KR20010043323A (ko) * 1998-05-06 2001-05-25 제넨테크, 인크. 이온 교환 크로마토그래피에 의한 단백질 정제 방법
ATE274522T1 (de) 1998-06-01 2004-09-15 Genentech Inc Abtrennung von antikörper-monomeren von deren multimeren mittels ionaustausch-chromatographie
US7265084B2 (en) 2001-10-10 2007-09-04 Neose Technologies, Inc. Glycopegylation methods and proteins/peptides produced by the methods
US7795210B2 (en) 2001-10-10 2010-09-14 Novo Nordisk A/S Protein remodeling methods and proteins/peptides produced by the methods
US7179617B2 (en) 2001-10-10 2007-02-20 Neose Technologies, Inc. Factor IX: remolding and glycoconjugation of Factor IX
ES2411007T3 (es) 2001-10-10 2013-07-04 Novo Nordisk A/S Remodelación y glicoconjugación de péptidos
US7473680B2 (en) 2001-11-28 2009-01-06 Neose Technologies, Inc. Remodeling and glycoconjugation of peptides
US7470779B2 (en) * 2002-09-20 2008-12-30 Pfizer Inc. Process for decreasing aggregate levels of pegylated protein
WO2006127896A2 (en) 2005-05-25 2006-11-30 Neose Technologies, Inc. Glycopegylated factor ix
CA2522345A1 (en) 2003-04-09 2004-11-18 Neose Technologies, Inc. Glycopegylation methods and proteins/peptides produced by the methods
CA2549413A1 (en) * 2003-12-03 2005-06-23 Neose Technologies, Inc. Glycopegylated factor ix
US20060040856A1 (en) * 2003-12-03 2006-02-23 Neose Technologies, Inc. Glycopegylated factor IX
CN102719508A (zh) 2005-08-19 2012-10-10 诺和诺德公司 糖基聚乙二醇化的因子vii和因子viia
US20070105755A1 (en) * 2005-10-26 2007-05-10 Neose Technologies, Inc. One pot desialylation and glycopegylation of therapeutic peptides
US8399632B2 (en) 2007-02-28 2013-03-19 Baxter International Inc. Method for the purification of recombinant blood coagulation factor IX enriched in sulfated and/or phosphorylated molecules
WO2008119815A1 (en) * 2007-04-02 2008-10-09 Novo Nordisk A/S Subcutaneous administration of coagulation factor ix

Similar Documents

Publication Publication Date Title
JP2013511566A5 (enExample)
JP2013514073A5 (enExample)
EA201171199A1 (ru) Способ очистки рекомбинантного фсг
ES2923018T3 (es) Métodos de purificación de ARN
BR112013030628A2 (pt) "métodos para produção de uma proteína purificada de interesse utilizando uma matriz de cromatografia de afinidade (ca), e de um anticorpo purificado, fragmento de anticorpo ou proteína de fusão de fc utilizando a coluna de proteína a".
JP2011525523A5 (enExample)
JP2012018171A5 (enExample)
PH12020500027A1 (en) Purification of iduronate-2-sulfatase
JP2011510303A5 (enExample)
JP2016519137A5 (enExample)
JP2012518034A5 (enExample)
GB2443505B (en) Nucleic acid purification method
JP2013503877A5 (enExample)
NZ603616A (en) Apparatus and process of purification of proteins
RU2014111820A (ru) Способы элиминации вируса
WO2010151632A8 (en) Protein purification by caprylic acid (octanoic acid ) precipitation
RU2019109975A (ru) Способы очистки антител
JP2014507368A5 (enExample)
TW201617360A (zh) 用於純化蛋白質之方法及試劑
RU2011125656A (ru) Очистка полипептидов
JP2014506874A5 (enExample)
FI3395423T3 (fi) Vuotaneen affiniteettipuhdistusligandin poistaminen
CN103725664A (zh) 一种高度纯化激肽释放酶的方法
JP2014193838A5 (enExample)
JP2008517046A5 (enExample)